Bibliometrics | Original trial characteristics | Follow-up trial characteristics |
---|---|---|
Authors | Trial name | Time since trial closure |
Title | Country of origin | |
Year of publication | Original authors (differ from follow-up study's authors?) | Data sources for follow-up outcomes (eg, health administrative, population registry, EMRs). Linkages fields and type linkage (probabilistic/deterministic); where was linkage conducted (eg, academic, government body, etc)? |
Publication source | Outcomes (primary and secondary) | Outcomes (primary and secondary); identification of extended trial outcomes: structured data (eg, claims data); unstructured data—information contained in text (eg, EMR) or other documents; technique used for extracting information: manual, text mining |
Journal impact (low/high) | Timeframe | |
Intervention applied | ||
Potential/realised clinical or policy implications | Were the conclusions of the original trial altered? | |
Funders | Potential/realised clinical or policy implications; for example, evidence supporting or against current guidelines | |
Comments regarding ethics approval | ||
Funders | ||
Challenges, time requirements and costs associated with extension | ||
Methodological issues (eg, unadjusted time-varying confounding) | ||
Stated reasons for trial extension (eg, long-term treatment effects, potential ‘legacy’ effects) |
EMR, electronic medical record.